<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00480207</url>
  </required_header>
  <id_info>
    <org_study_id>ICHN-4413</org_study_id>
    <nct_id>NCT00480207</nct_id>
  </id_info>
  <brief_title>Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults</brief_title>
  <official_title>Randomized Double-blind Controlled Clinical Trial to Assess the Impact of Folic Acid and Omega-3 Fatty Acids Supplementation on the Severity of Depressive Symptoms in Older Adults With Identified Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. RH Belmaker</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The S. Daniel Abraham International Center for Health and Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beersheva Mental Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our specific aim is to determine the impact of folic acid and omega-3 supplementation on the
      severity of depressive symptoms among depressed adults aged 65 and above.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the severity of depressive symptoms</measure>
    <time_frame>baseline, 4th , 8th and 12th week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cognitive status</measure>
    <time_frame>baseline, 4th, 8th, and 12th week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nutritional status</measure>
    <time_frame>baseline and end of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>possible side effects</measure>
    <time_frame>baseline, 4th, 8th, and 12th week</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>omega-3, folic acid, vitB12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>folic acid (1600 mcg per day), and omega-3 (2000 mg per day: active docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA), proportion 1:1), vitamin B12 (1000 mcg per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omega-3, folic acid placebo, vit B12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>omega-3,folic acid placebo (starch), vitamin B12 (1000 mcg per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omega-3 placebo, folic acid, vit B12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>folic acid, omega-3 placebo(canola oil),vitamin B12 (1000 mcg per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omega-3 placebo, folic acid placebo, vit B12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>omega-3 placebo (canola oil),folic acid placebo (starch), vitamin B12 (1000 mcg per day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <arm_group_label>omega-3, folic acid, vitB12</arm_group_label>
    <arm_group_label>omega-3 placebo, folic acid, vit B12</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>omega-3</intervention_name>
    <arm_group_label>omega-3, folic acid, vitB12</arm_group_label>
    <arm_group_label>omega-3, folic acid placebo, vit B12</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vit B12</intervention_name>
    <arm_group_label>omega-3, folic acid, vitB12</arm_group_label>
    <arm_group_label>omega-3, folic acid placebo, vit B12</arm_group_label>
    <arm_group_label>omega-3 placebo, folic acid, vit B12</arm_group_label>
    <arm_group_label>omega-3 placebo, folic acid placebo, vit B12</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>folic acid placebo</intervention_name>
    <arm_group_label>omega-3, folic acid placebo, vit B12</arm_group_label>
    <arm_group_label>omega-3 placebo, folic acid placebo, vit B12</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>omega-3 placebo</intervention_name>
    <arm_group_label>omega-3 placebo, folic acid, vit B12</arm_group_label>
    <arm_group_label>omega-3 placebo, folic acid placebo, vit B12</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 65+ (year of birth -1942 or below)

          2. Depression (as defined by the DSM-IV diagnostic criteria for depression: major or
             minor depression or dysthymia)

        Exclusion Criteria:

          1. Co-existing psychiatric disorder (except anxiety disorders)

          2. Moderate and severe cognitive impairment

          3. Current treatment with anticoagulants, antithrombotics and fibrinolytics

          4. Current severe angina with exertion

          5. Chronic renal insufficiency

          6. Liver cirrhosis

          7. Alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danit R Shahar, RD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Ben-Gurion University of the Negev</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alex Palatnik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beersheva Mental Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larissa German, MD, MMedSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>The S. Daniel Abraham International Center for Health and Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mental Health Center</name>
      <address>
        <city>Beer-Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2007</study_first_submitted>
  <study_first_submitted_qc>May 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2007</study_first_posted>
  <last_update_submitted>November 5, 2012</last_update_submitted>
  <last_update_submitted_qc>November 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beersheva Mental Health Center</investigator_affiliation>
    <investigator_full_name>Prof. RH Belmaker</investigator_full_name>
    <investigator_title>Prof. RH Belmaker</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

